The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome

Forensic Science International

Volumn 227, Issue 1-3, 2013, Pages 74-76

  Barbera, Nunziata ^a   Busardò, Francesco Paolo ^b   Indorato, Francesca ^a   Romano, Guido ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Adulterants; Caffeine; Dextromethorphan; Lidocaine

Indexed keywords

ACETYLCODEINE; BENZOYLECGONINE; CAFFEINE; CANNABINOID; CITALOPRAM; CODEINE; DEXTROMETHORPHAN; DIAMORPHINE; ILLICIT DRUG; LIDOCAINE; METHADONE; MORPHINE; MORPHINE 6 ACETATE; OPIATE; PARACETAMOL;

ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG OVERDOSE; DRUG POTENTIATION; FATALITY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG EDEMA; MACROPHAGE; MALE; PRIORITY JOURNAL;

ADULT; ANESTHETICS, LOCAL; ANTITUSSIVE AGENTS; BILE; BRAIN CHEMISTRY; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CITALOPRAM; CODEINE; DEXTROMETHORPHAN; DRUG CONTAMINATION; DRUG OVERDOSE; DRUG USERS; FEMALE; FORENSIC PATHOLOGY; FORENSIC TOXICOLOGY; GASTROINTESTINAL CONTENTS; HUMANS; KIDNEY; LIDOCAINE; LIVER; LUNG; MALE; METHADONE; MORPHINE; MORPHINE DERIVATIVES; NARCOTICS; PYRROLIDINES; SEROTONIN UPTAKE INHIBITORS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; VITREOUS BODY;

EID: 84875624091     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2012.08.041     Document Type: Article

References (25)

1. Karch S. The Pathology of Drug Abuse 2002, CRC Press, Boca Raton. third ed.
2. Bertol E., Mari F., Lodi F., Marozzi E. Trattato di Tossicologia Forense 2000, CEDAM, Padova. second ed.
3. Fucci N., De Giovanni N. Adulterants encountered in the illicit cocaine market. Forensic Sci. Int. 1998, 95:247-252.
4. Schneider S., Meys F. Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005 to 2010. Forensic Sci. Int. 2011, 212:242-246.
5. Ritchie M.J., Greene N.M. Anestetici locali. Le basi farmacologiche della terapia, 8th Rev. 1992, 289-307. Zanichelli, Bologna. L.S. Goodman, A.G. e Gilman (Eds.).
6. Benowitz N., Forsyth R.P., Melmon K.L., Rowland M. Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion mode. Clin. Pharmacol. Ther. 1974, 16:87-98.
7. Christie J.L. Fatal consequences of local anesthesia: report of five cases and a review of the literature. J. Forensic Sci. 1976, 21:671-679.
8. Poklis A., Mackell M.A., Tuker E.F. Tissue distribution of lidocaine after fatal accidental injection. J. Forensic Sci. 1984, 29:1229-1236.
9. Peat M.A., Deyman M.E., Crouch D.J., Margot P., Finkle B.S. Concentrations of lidocaine and monoethylglycylxylidide (MEGX) in lidocaine associated deaths. J. Forensic Sci. 1985, 30:1048-1057.
10. Huang Y.F., Upton R.N., Rutten A.J., Runciman W.B. IV bolus administration of subconvulsive doses of lignocaine to conscious sheep: effects on circulatory function. Br. J. Anaesth. 1992, 69:368-374.
11. Santangelo F., Barbera N., Rossitto C., Sgarlata M., Spadaro G., Romano G. Considerazioni tossicologiche su un caso di overdose da lidocaina. Bollettino della Società Medico Chirurgica di Catania 2001, LXXI:52-60.
12. Musshoff F., Schmidt P., Madea B. Fatality caused by a combined trimipramine-citalopram intoxication. Forensic Sci. Int. 1999, 106:125-131.
13. Zehnder M., Hohnloser S., Just H. QT-interval prolonging drugs: mechanism and clinical relevance of their arrhythmogenic hazards. Cardiovasc. Drugs Ther. 1991, 5:515-530.
14. Boison D. Methylxanthines, seizures, and excitotoxicity. Handb. Exp. Pharmacol. 2011, 200:251-266.
15. Cannon M.E., Cooke C.T., McCarthy J.S. Caffeine-induced cardiac arrhythmia: an unrecognised danger of healthfood products. Med. J. Aust. 2001, 174:520-521.
16. Jorgensen F. Desktrometorfanmisbrug. Abuse of dextromethorphan. Ugeskr. Laeger 1967, 36:1148-1150.
17. Banken J.A., Foster H. Dextromethorphan an emerging drug of abuse. Ann. N. Y. Acad. Sci. 2008, 1139:402-411.
18. Wilson M.D., Ferguson R.W., Mazer M.E., Litovits T.L. Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000-2010. Clin. Toxicol. 2011, 49:409-415.
19. Rammer L., Holmgren P., Sandler H. Fatal intoxication by dextromethorphan: a report on two cases. Forensic Sci. Int. 1988, 37:233-236.
20. Foutz A.S., Champagnat J., Denavit-Saubié M. Involvement of N-methyl-d-aspartate (NMDA) receptors in respiratory rhythm genesis. Brain Res. 1989, 500:199-208.
21. Foutz A.S., Pierrefiche O., Denavit-Saubié M. Combined blockade of NMDA and non-NMDA receptors produces respiratory arrest in the adult cat. Neuroreport 1994, 5:481-484.
22. Hoffmann V.L., Vermeyen K.M., Adriaensen H.F., Meert T.F. Effects of NMDA receptor antagonists on opioid-induced respiratory depression and acute antinociception in rats. Pharmacol. Biochem. Behav. 2003, 74:933-941.
23. Trujillo K.A., Akil H. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality. Pharmacol. Biochem. Behav. 1991, 38:673-675.
24. Kukanich B., Papich M.G. Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs. J. Vet. Pharmacol. Ther. 2004, 27:337-341.
25. Barbera N., Indorato F., Ragazzi G., Romano G. Three lethal cases of heroin cut with dextromethorphan. Bollettino sulle Dipendenze 2011, XXXIVI:69-76.